Risto Arvo Sakari Lammintausta
Founder at Forendo Pharma Oy
Network origin in Risto Arvo Sakari Lammintausta first degree
Entity | Entity type | Industry | |
---|---|---|---|
Forendo Pharma Oy
Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland.
12
| Subsidiary | Pharmaceuticals: Major | 12 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Risto Arvo Sakari Lammintausta via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of London | College/University | Doctorate Degree | |
Technical University of Denmark | College/University | Graduate Degree Graduate Degree Graduate Degree | |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
University College London | College/University | Undergraduate Degree | |
University of Copenhagen | College/University | Graduate Degree | |
Aescap Venture Management BV
Aescap Venture Management BV Investment ManagersFinance Aescap Venture Management BV is an independent venture capital investment firm based in Amsterdam. Aescap was founded in 2005 by Michiel de Haan and Dinko Valerio. Inspired by the name of the Greek god of healthcare, Aesculapiu, the firm's name is an acronym for 'Accelerating European Science Companies and Products.' The firm focuses on developing growth in European firms in the biomedical sector. | Investment Managers | Private Equity Investor | |
Humboldt-Universität zu Berlin | College/University | Doctorate Degree | |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | Medical Specialties | Director/Board Member | |
Sunstone Capital A/S
Sunstone Capital A/S Investment ManagersFinance Sunstone Capital A/S (Sunstone) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2007 by Peter Benson, Sten Verland, and Søren Lemonius, and invests on behalf of a group of institutional investors. | Investment Managers | Private Equity Investor | |
EpiTherapeutics ApS
EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member Director/Board Member | |
Novo Seeds
Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Director of Investments | |
Life Science Ventures
Life Science Ventures Investment ManagersFinance Life Science Ventures provides financial advice. | Investment Managers | Corporate Officer/Principal | |
Sunstone LSV General Partner I ApS | Corporate Officer/Principal | ||
Radiometer Medical ApS
Radiometer Medical ApS Medical SpecialtiesHealth Technology Part of Danaher Corp., Radiometer Medical ApS is a Danish company that develops, manufactures, and markets solutions for blood sampling, blood gas analysis, transcutaneous monitoring, immunoassay testing, and related IT management systems. The company is based in Brønshøj, Denmark. The company's solutions enable the assessment of wounds and vascular disease, particularly Peripheral Artery Disease, and provide streamlined quality control data management and compliance. The company's AQURE POC IT solution offers a complete overview and centralized control of point-of-care testing setups, including quality control management, device and operator competency management, and sample workflow safeguarding. Radiometer Medical was founded in 1935 by Carl Schrøder and Børge Aagaard. | Medical Specialties | Corporate Officer/Principal | |
CANTARGIA AB | Pharmaceuticals: Major | Director/Board Member | |
ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member | |
ACARIX AB | Medical Specialties | Director/Board Member | |
FBC Device ApS
FBC Device ApS Medical SpecialtiesHealth Technology FBC Device ApS provides spinal implants for the treatment of degenerative disc disease. Its products include Statur-L. The firm develops and manufactures healthcare equipment that helps in the placement of spine in correct position after an implant surgery. The company was founded by Finn Bjarke Christensen in 2005 and is headquartered in Risskov, Denmark. | Medical Specialties | Director/Board Member | |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
FOLLICUM AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
Asceneuron SA
Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
SynAffix BV
SynAffix BV BiotechnologyHealth Technology SynAffix BV develops next-generation antibody-drug conjugates for targeted cancer and other diseases. The application of the firm?s proprietary GlycoConnect technology, comprising precision modification of a protein's native glycosylation site, allows the fast and simple construction of antibody-drug conjugates that are both stable and homogeneous. The company was founded by Floris van Delft and Sander van Berkel in 2010 and is headquartered in Oss, the Netherlands. | Biotechnology | Director/Board Member | |
PROGYNY, INC. | Miscellaneous Commercial Services | Director/Board Member | |
Sunstone LSV Partners & Co. Holding III ApS | Chief Executive Officer | ||
Sunstone LSV Partners Holding III ApS | Chief Executive Officer | ||
Sunstone LSV Invest III Holding ApS | Chief Executive Officer | ||
Sunstone LSV & Co. Special Limited Partner III Holding ApS | Chief Executive Officer | ||
Sunstone LSV Invest III ApS | Chief Executive Officer | ||
Sunstone LSV Special Limited Partner III Aps | Chief Executive Officer | ||
IO Biotech ApS
IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Director/Board Member Director/Board Member | |
Merck Ventures BV
Merck Ventures BV Investment ManagersFinance Merck Ventures BV (Merck Ventures) is a venture capital arm of Merck KGaA founded in 2009. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor | |
Acarix A/S
Acarix A/S Medical SpecialtiesHealth Technology Acarix A/S engages in development, production and advertisement of a new cardiovascular diagnostic methods and equipment. It develops engages in the non-invasive and non-radiation acoustic detection of coronary artery disease. The firm designs CADScor, a sensor that records, processes, and displays heart signal. The company was founded in 2009 and is headquartered in Kongens Lyngby, Denmark. | Medical Specialties | Director/Board Member | |
Scenic Biotech BV
Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Scenic Biotech BV is using genomics to develop innovative therapies for patients affected by severe diseases. The company was founded by Thijn Brummelkamp and Sebastian Nijman and is headquartered in Amsterdam, Netherlands. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Sunstone Life Science Ventures A/S
Sunstone Life Science Ventures A/S Financial ConglomeratesFinance Part of Sunstone Capital A/S, Sunstone Life Science Ventures A/S is a Danish company that provides investment services. The company is based in Copenhagen, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
ReWind Therapeutics NV
ReWind Therapeutics NV Pharmaceuticals: MajorHealth Technology ReWind Therapeutics NV is a biotech company based in Leuven, Belgium that develops first-in-class remyelinating therapies for myelin-related diseases. The Belgian company's aim is to bring these therapies into fast-track clinical development. Myelin-related diseases, such as multiple sclerosis, are those where the myelin sheath surrounding nerves is damaged, leading to deficient nerve transmission that may affect multiple functions, including sensation, cognition, and movement, among others. ReWind Therapeutics develops first-in-class therapeutics designed to re-initiate the process of remyelination in patients suffering from major debilitating diseases such as multiple sclerosis, optic neuritis, or nerve injuries. The company's team has extensive R&D expertise and has built a strong patent estate for developing novel remyelination therapeutics. The company was founded in 2017 by Ku Leuven's Centre for Drug Design and Discovery (CD3) and Axxam S.p.A. The CEO of the company since 2021 is Anja Harmeier. | Pharmaceuticals: Major | Director/Board Member | |
Sunstone LSV General Partner Ill ApS
Sunstone LSV General Partner Ill ApS Financial ConglomeratesFinance Part of Sunstone Capital A/S, Sunstone LSV General Partner Ill ApS functions as an investment holding Danish company. The company is based in Copenhagen, Denmark. The CEO of the company is Claus Asbjørn Andersson. | Financial Conglomerates | Chief Executive Officer | |
Abinitio ApS
Abinitio ApS Financial ConglomeratesFinance Abinitio ApS is an investment holding Danish company. The private company is based in Copenhagen, Denmark. The CEO of the company is Claus Asbjørn Andersson. | Financial Conglomerates | Chief Executive Officer | |
Sunstone Lsv General Partner Ii ApS
Sunstone Lsv General Partner Ii ApS Financial ConglomeratesFinance Sunstone Lsv General Partner Ii ApS functions as an investment holding Danish company. The private company is based in Copenhagen, Denmark. | Financial Conglomerates | Director/Board Member | |
Sunstone Lsv & Co. Invest Ill Holding Aps
Sunstone Lsv & Co. Invest Ill Holding Aps Financial ConglomeratesFinance Sunstone Lsv & Co. The private company is based in Copenhagen, Denmark. Invest Ill Holding Aps functions as an investment holding Danish company. | Financial Conglomerates | Chief Executive Officer | |
Asbjørn Andersson ApS | Chief Executive Officer | ||
GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
IO BIOTECH, INC. | Biotechnology | Director/Board Member |
Statistics
International
Denmark | 32 |
United States | 6 |
Netherlands | 5 |
United Kingdom | 4 |
Sweden | 4 |
Sectoral
Health Technology | 23 |
Finance | 12 |
Consumer Services | 6 |
Commercial Services | 3 |
Electronic Technology | 2 |
Operational
Director/Board Member | 140 |
Corporate Officer/Principal | 38 |
Chairman | 23 |
Chief Executive Officer | 20 |
Independent Dir/Board Member | 16 |
Most connected contacts
Insiders | |
---|---|
Viktor Drvota | 41 |
Claus Asbjørn Andersson | 41 |
Stéphane Verdood | 32 |
Stephan Christgau | 29 |
Cristina Csimma | 21 |
Søren Møller | 21 |
Anja Koenig | 19 |
Hakan Goker | 18 |
David Colpman | 15 |
Lauri Kangas | 2 |
Pasi Koskimies | 1 |
Kira Wahlstedt-Lindström | 1 |
- Stock Market
- Insiders
- Risto Arvo Sakari Lammintausta
- Company connections